4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene

C31H23N5 — CID 118569274

IUPAC4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene
SMILESCc1nc2c3c(ccc2[nH]1)-c1ccc(-c2ccc4c(c2)c2ncccc2c2nc(C)[nH]c42)cc1CC3
InChIInChI=1S/C31H23N5/c1-16-33-27-12-11-22-21-8-5-18(14-20(21)7-10-23(22)29(27)34-16)19-6-9-24-26(15-19)28-25(4-3-13-32-28)31-30(24)35-17(2)36-31/h3-6,8-9,11-15H,7,10H2,1-2H3,(H,33,34)(H,35,36)
InChIKeyLQXUKZVGZSYJRH-UHFFFAOYSA-N
MW465.56 g/mol
LogP7.19
Rot. Bonds1

About 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene

4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene (PubChem CID 118569274) has the molecular formula C31H23N5 and a molecular weight of 465.56 g/mol. Its IUPAC name is 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene.

Molecular Properties

Compound Name4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene
PubChem CID118569274
Molecular FormulaC31H23N5
Molecular Weight465.56 g/mol
Exact Mass465.20
IUPAC Name4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene
SMILESCc1nc2c3c(ccc2[nH]1)-c1ccc(-c2ccc4c(c2)c2ncccc2c2nc(C)[nH]c42)cc1CC3
InChIInChI=1S/C31H23N5/c1-16-33-27-12-11-22-21-8-5-18(14-20(21)7-10-23(22)29(27)34-16)19-6-9-24-26(15-19)28-25(4-3-13-32-28)31-30(24)35-17(2)36-31/h3-6,8-9,11-15H,7,10H2,1-2H3,(H,33,34)(H,35,36)
InChIKeyLQXUKZVGZSYJRH-UHFFFAOYSA-N
XLogP7.19
TPSA70.25 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds1
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500465.56
LogP ≤ 57.19
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene?
The IUPAC name of 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene (CID 118569274) is 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene.
What is the SMILES notation for 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene?
The canonical SMILES for 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene is Cc1nc2c3c(ccc2[nH]1)-c1ccc(-c2ccc4c(c2)c2ncccc2c2nc(C)[nH]c42)cc1CC3.
What is the InChIKey of 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene?
The InChIKey is LQXUKZVGZSYJRH-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H23N5/c1-16-33-27-12-11-22-21-8-5-18(14-20(21)7-10-23(22)29(27)34-16)19-6-9-24-26(15-19)28-25(4-3-13-32-28)31-30(24)35-17(2)36-31/h3-6,8-9,11-15H,7,10H2,1-2H3,(H,33,34)(H,35,36).
What are the key properties of 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene?
4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene has a molecular weight of 465.56 g/mol, XLogP of 7.19, 1 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methyl-15-(2-methyl-4,5-dihydro-1H-naphtho[2,1-e]benzimidazol-7-yl)-3,5,11-triazatetracyclo[11.4.0.02,6.07,12]heptadeca-1(13),2(6),4,7(12),8,10,14,16-octaene is sourced from PubChem (CID 118569274), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).